The Evolution of Tissue Engineered Vascular Graft Technologies: From Preclinical Trials to Advancing Patient Care
Currently available synthetic grafts have contributed to improved outcomes in cardiovascular surgery. However, the implementation of these graft materials at small diameters have demonstrated poor patency, inhibiting their use for coronary artery bypass surgery in adults. Additionally, when applied...
Main Authors: | Yuichi Matsuzaki, Kelly John, Toshihiro Shoji, Toshiharu Shinoka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/9/7/1274 |
Similar Items
-
Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts
by: Yuichi Matsuzaki, et al.
Published: (2021-05-01) -
Novel reinforcement of corrugated nanofiber tissue-engineered vascular graft to prevent aneurysm formation for arteriovenous shunts in an ovine model
by: Hiroshi Matsushita, MD, et al.
Published: (2022-01-01) -
Clinical Application for Tissue Engineering Focused on Materials
by: Takahiro Kitsuka, et al.
Published: (2022-06-01) -
Comparison of Clinical Outcomes in Patients Undergoing a Salvage Procedure for Thrombosed Hemodialysis Arteriovenous Grafts
by: You Kyeong Park, et al.
Published: (2021-12-01) -
Evaluation of tissue-engineered human acellular vessels as a Blalock–Taussig–Thomas shunt in a juvenile primate modelCentral MessagePerspective
by: Kevin M. Nash, PhD, et al.
Published: (2023-09-01)